|
|||||
|
|
A randomized,crossover phase 1 study to assess the effects of formulation (capsule vs tablet) and meal consumption on the bioavailability of dovitinib (TKI258) |
|
| Authors: | Jeffrey R. Infante Ramesh K. Ramanathan Daniel George Eugene Tan Michelle Quinlan Angela Liu Jeffrey W. Scott Sunil Sharma |
| Affiliation: | 1. Sarah Cannon Research Institute, Nashville, TN, USA 2. Virginia G. Piper Cancer Center, Scottsdale, AZ, USA 3. Duke University School of Medicine, Durham, NC, USA 4. Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA 5. Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope Dr, Rm 3360, Salt Lake City, UT, 84112, USA |
| Abstract: | |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |